Zhejiang Hisun Pharmaceutical Co Ltd (600267) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥438.43 Million ≈ $64.16 Million USD) by net assets (CN¥8.76 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Hisun Pharmaceutical Co Ltd (600267) net asset quality to measure how much of total assets are equity-financed.

Zhejiang Hisun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Zhejiang Hisun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600267 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Hisun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Hisun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Diamondrock Hospitality Company Common Stock
NYSE:DRH
0.015x
Sino-Platinum Metals Co Ltd
SHG:600459
-0.104x
OEM International AB (publ)
ST:OEM-B
0.095x
ChipMOS Technologies
TW:8150
0.013x
Energa S.A.
WAR:ENG
0.085x
Inari Amertron Bhd
KLSE:0166
0.027x
Northwest Bancshares Inc
NASDAQ:NWBI
0.039x
Xinxing Ductile Iron Pipes Co Ltd
SHE:000778
-0.010x

Annual Cash Flow Conversion Efficiency for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Zhejiang Hisun Pharmaceutical Co Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.85 Billion
≈ $1.30 Billion
CN¥2.03 Billion
≈ $297.30 Million
0.230x -6.88%
2024-12-31 CN¥8.58 Billion
≈ $1.26 Billion
CN¥2.11 Billion
≈ $309.42 Million
0.246x +35.66%
2023-12-31 CN¥8.35 Billion
≈ $1.22 Billion
CN¥1.52 Billion
≈ $221.98 Million
0.182x -26.73%
2022-12-31 CN¥8.33 Billion
≈ $1.22 Billion
CN¥2.07 Billion
≈ $302.28 Million
0.248x +4.90%
2021-12-31 CN¥7.35 Billion
≈ $1.07 Billion
CN¥1.74 Billion
≈ $254.11 Million
0.236x +22.79%
2020-12-31 CN¥8.26 Billion
≈ $1.21 Billion
CN¥1.59 Billion
≈ $232.61 Million
0.193x +111.79%
2019-12-31 CN¥7.68 Billion
≈ $1.12 Billion
CN¥698.39 Million
≈ $102.20 Million
0.091x -53.62%
2018-12-31 CN¥7.38 Billion
≈ $1.08 Billion
CN¥1.45 Billion
≈ $211.64 Million
0.196x +24.42%
2017-12-31 CN¥7.88 Billion
≈ $1.15 Billion
CN¥1.24 Billion
≈ $181.55 Million
0.158x +63.23%
2016-12-31 CN¥8.04 Billion
≈ $1.18 Billion
CN¥775.90 Million
≈ $113.54 Million
0.097x +7.05%
2015-12-31 CN¥8.17 Billion
≈ $1.19 Billion
CN¥736.17 Million
≈ $107.72 Million
0.090x +30.49%
2014-12-31 CN¥8.26 Billion
≈ $1.21 Billion
CN¥571.04 Million
≈ $83.56 Million
0.069x -21.92%
2013-12-31 CN¥5.96 Billion
≈ $871.87 Million
CN¥527.25 Million
≈ $77.15 Million
0.088x +22.41%
2012-12-31 CN¥5.20 Billion
≈ $760.59 Million
CN¥375.75 Million
≈ $54.98 Million
0.072x -36.79%
2011-12-31 CN¥4.59 Billion
≈ $672.18 Million
CN¥525.31 Million
≈ $76.87 Million
0.114x -38.37%
2010-12-31 CN¥2.74 Billion
≈ $401.57 Million
CN¥509.18 Million
≈ $74.51 Million
0.186x -4.62%
2009-12-31 CN¥2.43 Billion
≈ $355.67 Million
CN¥472.85 Million
≈ $69.19 Million
0.195x +36.20%
2008-12-31 CN¥1.55 Billion
≈ $226.70 Million
CN¥221.28 Million
≈ $32.38 Million
0.143x -55.07%
2007-12-31 CN¥1.38 Billion
≈ $201.50 Million
CN¥437.72 Million
≈ $64.05 Million
0.318x +273.86%
2006-12-31 CN¥1.27 Billion
≈ $185.92 Million
CN¥108.03 Million
≈ $15.81 Million
0.085x -8.03%
2005-12-31 CN¥1.23 Billion
≈ $179.69 Million
CN¥113.53 Million
≈ $16.61 Million
0.092x -64.49%
2004-12-31 CN¥1.20 Billion
≈ $175.90 Million
CN¥312.93 Million
≈ $45.79 Million
0.260x -9.59%
2003-12-31 CN¥1.00 Billion
≈ $146.59 Million
CN¥288.45 Million
≈ $42.21 Million
0.288x +96.58%
2002-12-31 CN¥824.83 Million
≈ $120.70 Million
CN¥120.82 Million
≈ $17.68 Million
0.146x +66.14%
2001-12-31 CN¥784.18 Million
≈ $114.75 Million
CN¥69.14 Million
≈ $10.12 Million
0.088x +19.97%
2000-12-31 CN¥757.90 Million
≈ $110.90 Million
CN¥55.70 Million
≈ $8.15 Million
0.073x -43.75%
1999-12-31 CN¥249.88 Million
≈ $36.56 Million
CN¥32.64 Million
≈ $4.78 Million
0.131x --

About Zhejiang Hisun Pharmaceutical Co Ltd

SHG:600267 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.19 Billion
CN¥14.96 Billion CNY
Market Cap Rank
#5823 Global
#1066 in China
Share Price
CN¥12.48
Change (1 day)
+2.46%
52-Week Range
CN¥9.48 - CN¥12.48
All Time High
CN¥20.23
About

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small mol… Read more